This document discusses a novel machine learning approach using support vector machines (SVM) to develop a retinal therapeutic for glaucoma, achieving a 94% success rate in testing on images of both healthy and glaucomatous retinas. Glaucoma is characterized by optic nerve damage leading to vision loss and is classified into various types, including open-angle and closed-angle glaucoma. The paper also explains the clustering algorithm utilized in the SVM method to improve classification and analysis of glaucoma-related data.